CAS 114200-31-6
:1-Pyrrolidineacetamide,2-oxo-3-[[(2S)-2-pyrrolidinylcarbonyl]amino]-, (3R)-
Description:
1-Pyrrolidineacetamide, 2-oxo-3-[[(2S)-2-pyrrolidinylcarbonyl]amino]-, (3R)-, with CAS number 114200-31-6, is a chemical compound characterized by its complex structure that includes a pyrrolidine ring and an amide functional group. This compound is typically classified as a derivative of pyrrolidine, which is a five-membered saturated heterocyclic amine. The presence of the 2-oxo group indicates that it contains a carbonyl functional group, contributing to its reactivity and potential biological activity. The stereochemistry, denoted by the (2S) and (3R) designations, suggests specific spatial arrangements of atoms that can influence the compound's interactions and properties. Such compounds may exhibit various pharmacological activities, making them of interest in medicinal chemistry. Additionally, the presence of multiple functional groups may allow for diverse chemical reactivity, including potential applications in drug development or as intermediates in organic synthesis. Overall, the characteristics of this compound highlight its potential significance in both research and application within the field of chemistry.
Formula:C11H18N4O3
Synonyms:- 1-Pyrrolidineacetamide,2-oxo-3-[(2-pyrrolidinylcarbonyl)amino]-, [R-(R*,S*)]-
- Paopa
- PAOPA (S)-N-((R)-1-(2-amino-2-oxoethyl)-2-oxopyrrolidin-3-yl)pyrrolidine-2-carboxamide
- (3R)-2-Oxo-3-[[(2S)-2-Pyrrolidinylcarbonyl]amino]-1-pyrrolidineacetamide
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
PAOPA
CAS:<p>PAOPA is a tyrosinase inhibitor that has been shown to be a potent and selective competitive inhibitor of tyrosinase. It has been shown to inhibit the dopamine-induced tyrosinase activity in rat striatal membranes. PAOPA also blocks the binding of L-DOPA to its receptor, and inhibits the synthesis of melanin by inhibiting the conversion of DOPA to dopaquinone. The low bioavailability of PAOPA may be due to its poor absorption from the gastrointestinal tract and rapid metabolism in liver. PAOPA is effective when used at doses greater than 10 mg/kg body weight.</p>Formula:C11H18N4O3Purity:Min. 95%Molecular weight:254.29 g/molPAOPA
CAS:dopamine D2 receptor modulatorFormula:C11H18N4O3Purity:>99.99%Color and Shape:SolidMolecular weight:254.29



